Abstract

Clinical Trial

Evaluation of the Clinical Rationality of the use of Cefazoxime Sodium for Injection in 328 Cases

Xingnong Xu, Zhe Ding* and Lei Ma*

Published: 18 July, 2025 | Volume 9 - Issue 1 | Pages: 005-008

Objective: To study the use of cefazoxime sodium for injection in inpatients of the Third People’s Hospital of Yancheng City, and to provide reference for the rational clinical use of cefazoxime sodium. 
Methods: A retrospective study method was used to retrieve the medical records of patients discharged from 2 departments of urology and general surgery of the hospital using cefazoxime sodium in June-August 2023, and the rationality of the clinical use of injectable cefazoxime sodium was evaluated with reference to the relevant standards. 
Results: A total of 328 valid cases were included, of which 6 cases did not meet the dosage criteria, 10 cases did not meet the treatment time criteria; 44 cases did not meet the indication criteria. The comprehensive judgement of the reasonableness of the clinical use of cefazoxime sodium for injection resulted in 272 cases of reasonable use of the drug; 56 cases of unreasonable use of the drug. 
Conclusion: The clinical use of cefazoxime sodium for injection in this hospital is irrational and needs to be further strengthened and corrected.

Read Full Article HTML DOI: 10.29328/journal.ibm.1001030 Cite this Article Read Full Article PDF

Keywords:

Cefazoxime sodium for injection; Evaluation criteria; Rational use

References

  1. Revision Working Group for the Guidelines on Clinical Application of Antimicrobial Agents. Guidelines for Clinical Application of Antimicrobial Agents (2015 Edition) [Internet]. 2015 Jun 15 [cited 2024 Apr 11].
  2. Richards DM, Heel RC. Ceftizoxime, a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985;29(4):281-9. Available from: https://doi.org/10.2165/00003495-198529040-00001
  3. Zheng J, Long L, Yuan S. Clinical efficacy of commonly used clinical antimicrobials in the treatment of Klebsiella pneumoniae infections. World Notes on Antibiotics. 2021;42(5):286-9.
  4. Dai ZY, Wang F, Zhang YY. Practical Anti-Infective Therapy. Beijing: People's Medical Publishing House; 2004.
  5. Li T. Comparison of the efficacy of cefozoxime sodium and ceftriaxone sodium in the treatment of lower respiratory tract infections. Chinese Journal of Modern Drug Application. 2014;8(19):116-7.
  6. Jia YC, Zhang HT. Cost-effectiveness comparison of five antibiotics for the treatment of lower respiratory tract infections (gatifloxacin, moxifloxacin, ceftriaxone sodium, ceftazidime, cefazoxime). Science and Technology. 2015;5(11):255-6.
  7. Professional Committee of Infectious Diseases, China Medical Education Association. Expert Consensus on the Clinical Application of Antimicrobial Pharmacokinetics/Pharmacodynamics Theory. Chinese Journal of Tuberculosis and Respiratory Diseases. 2018;41(6):409-47.
  8. Li YY, Pei F. Resistance mutation selection window and antimicrobial drug anti-mutagenic concentration. Chinese Journal of Clinical Pharmacology and Therapeutics. 2004;9(1):1-7. Available from: https://manu41.magtech.com.cn/Jweb_clyl/EN/volumn/volumn_1331.shtml
  9. Liu TH, Xing M, Song GW. Research and application of the theory of selection window for bacterial drug resistance mutations. Pharmaceutical Care and Research. 2009;29(1):9-12.
  10. May AK, Fleming SB, Carpenter RO, Diaz JJ, Guillamondegui OD, Deppen SA, et al. Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients. Surg Infect (Larchmt). 2006;7(5):409-17. Available from: https://doi.org/10.1089/sur.2006.7.409
  11. Ozkurt Z, Erol S, Kadanali A, Ertek M, Ozden K, Tasyaran MA. Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists. Jpn J Infect Dis. 2005;58(6):338-43. Available from: https://pubmed.ncbi.nlm.nih.gov/16377863/
  12. Zhao YH, Hou QY, Gu K. Evaluation of antimicrobial drug application in 820 hospitalized patients. Evaluation and Analysis of Drug-Use in Hospitals of China. 2008;8(2):92-3.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?